Complications After Intravitreal Injection Aggravate
Clusters of inflammatory responses after intravitreal injections have unnerved some specialists, who will share their experiences and best practices at the upcoming American Society of Retina Specialists (ASRS) 2018 Annual Meeting, according to a report in Medscape.
“This is a hot topic in the retina community,” Timothy Murray, MD, from Murray Ocular Oncology and Retina in Miami, told Medscape Medical News. “Some doctors have had six patients in one day,” said Murray, who is program chair for the meeting. “You can imagine how terrifying that is.”
Late-breaking studies on new treatment approaches will include the phase 2 LADDER trial of a novel “port delivery system” for ranibizumab in patients with subfoveal neovascular age-related macular degeneration (NCT02510794). The system involves a durable intravitreal implant, placed through a scleral incision during a one-time surgical procedure, that can be refilled with a proprietary needle in an office setting.